Baker Brothers portfolio, Q3 2024

Baker Bros. Advisors · 13F for the quarter ending Sep 30, 2024

For Q3 2024, Baker Bros. Advisors reported $9.6B across 93 US-listed positions, led by ONC (24.6%), INCY (21.1%) and ACAD (6.8%). Compared with its filing for Q2 2024, Baker Brothers opened 5 new positions, added to 16, reduced 2 and sold out of 7; 69 positions did not change.

The largest purchase was an addition to INSM ($61.3M); the largest sale, the sale of the whole position in Insmed Incorporated ($56.2M).

Reported value
$9.6B
Positions
93
In the top 10
78%
Filed
Nov 14
2024

Key facts

13F portfolio value
$9.6BQ3 2024
Positions
93
Largest holding
ONC 24.6%
New positions
5
Sold out
7
Filed
Nov 14, 2024

Holdings as of (Q3 2024), filed with the SEC on . Changes are measured against the filing for Jun 30, 2024. Every tracked investor's Q3 2024 13F.

Bought and sold in Q3 2024

Baker Brothers: buys and sells in Q3 2024
StockMoveSharesSizeOf portfolio
Insmed IncINSM▲ Added 23%+839.88K$61.3M0.64%
Insmed Incorporatedno ticker on file
▼ Sold out—$56.2M0.58%
CRISPR Therapeutics AGCRSP▲ Added 743%+743.08K$34.9M0.36%
HOOKIPA Pharma Incno ticker on file
▼ Reduced 90%−7.32M$31.5M0.33%
Cerevel Therapeutics Hldngno ticker on file
▼ Sold out−683.59K$28M0.29%
Summit Therapeutics IncSMMT▲ Added 5.2%+1.2M$26.3M0.27%
Immunovant IncIMVT▲ Added 164%+760.69K$21.7M0.22%
Bicara Therapeutics IncBCAX▲ New+833.33K$21.2M0.22%
Praxis Precision MedicinesPRAX▲ Added 146%+191.57K$11M0.11%
Replimune Group IncREPL▲ Added 10.0%+1M$11M0.11%
Centessa Pharmaceuticals PLCno ticker on file
▲ Added 123%+677.97K$10.8M0.11%
Arvinas IncARVN▲ New+405.58K$10M0.10%
Ionis Pharmaceuticals IncIONS▲ New+223.47K$9M0.09%
Athira Pharma Incno ticker on file
▼ Sold out−3.15M$8.4M0.09%
Ultragenyx PharmaceuticalRARE▲ Added 7.5%+109.57K$6.1M0.06%
Talis Biomedical Corpno ticker on file
▼ Sold out−508.32K$4.4M0.05%
Structure Therapeutics IncGPCR▲ New+85.5K$3.8M0.04%
Skye Bioscience IncSKYE▲ Added 187%+934.63K$3.7M0.04%
Wave Life Sciences LtdWVE▲ New+344.06K$2.8M0.03%
Xencor IncXNCR▲ Added 23%+125K$2.5M0.03%
Adaptimmune Therapeuticsno ticker on file
▼ Sold out−2.34M$2.3M0.02%
Sage Therapeutics Incno ticker on file
▼ Sold out−171.03K$1.9M0.02%
Generation Bio Cono ticker on file
▲ Added 61%+737.99K$1.8M0.02%
Achilles Therapeutics plcno ticker on file
▼ Sold out−1.11M$903.6K0.01%
Design Therapeutics IncDSGN▲ Added 2.9%+48.43K$260.6K0.00%
IGM Biosciences Incno ticker on file
▲ Added 0.05%+1.99K$33K0.00%
Incyte CorpINCY▲ Added 0.00%+496$32.8K0.00%
Newamsterdam Pharma CompanyNAMS▼ Reduced 0.1%−116$1.9K0.00%
Rhythm Pharmaceuticals IncRYTM▲ Added 0.00%+1$52.40.00%
Kymera Therapeutics IncKYMR▲ Added 0.00%+1$47.30.00%

Holdings at the quarter's end

Baker Brothers holdings, Q3 2024
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q2 2024
1Beone Medicines LtdONC · SPONSORED ADSHealth Care24.6%$2.4B10.57M$224.512+ qtrsNo change
2Incyte CorpINCYHealth Care21.1%$2B30.74M$66.102+ qtrs▲ Added 0.00%
3Acadia Pharmaceuticals IncACAD—6.84%$659.5M42.88M$15.382+ qtrsNo change
4Summit Therapeutics IncSMMTHealth Care5.54%$534.9M24.42M$21.902+ qtrs▲ Added 5.2%
5Madrigal Pharmaceuticals IncMDGLHealth Care4.34%$419M1.97M$212.222+ qtrsNo change
6Revolution Medicines IncRVMDHealth Care3.56%$343.3M7.57M$45.352+ qtrsNo change
7Rhythm Pharmaceuticals IncRYTMHealth Care3.47%$335.2M6.4M$52.392+ qtrs▲ Added 0.00%
8Insmed IncINSMHealth Care3.34%$322.4M4.42M$73.002+ qtrs▲ Added 23%
9Kymera Therapeutics IncKYMRHealth Care2.94%$283.8M6M$47.332+ qtrs▲ Added 0.00%
10Bicycle Therapeutics PlcBCYC · SPONSORED ADS—2.21%$212.7M9.4M$22.632+ qtrsNo change
11Edgewise Therapeutics IncEWTXHealth Care1.62%$155.9M5.84M$26.692+ qtrsNo change
12Replimune Group IncREPL—1.26%$121.1M11.05M$10.962+ qtrs▲ Added 10.0%
13Alkermes PLCALKS · SHSHealth Care1.21%$117M4.18M$27.992+ qtrsNo change
14Denali Therapeutics IncDNLI—1.13%$108.7M3.73M$29.132+ qtrsNo change
15
Insmed Incno ticker on file · NOTE 0.75% 6/1/2028
—1.02%$98.3M——2+ qtrsNo change
16Ultragenyx PharmaceuticalRARE—0.91%$87.6M1.58M$55.552+ qtrs▲ Added 7.5%
17Nurix Therapeutics IncNRIX—0.90%$87.2M3.88M$22.472+ qtrsNo change
18Entrada Therapeutics IncTRDA—0.81%$77.8M4.87M$15.982+ qtrsNo change
19Immatics N.V.IMTX · SHS—0.76%$73.5M6.44M$11.412+ qtrsNo change
20Abcellera Biologics IncABCL—0.74%$71.6M27.53M$2.602+ qtrsNo change
21Kiniksa Pharmaceuticals InternationalKNSA · ORD SHS CL AHealth Care0.73%$70.4M2.82M$24.992+ qtrsNo change
22
IGM Biosciences Incno ticker on file
—0.70%$67.7M4.09M$16.542+ qtrs▲ Added 0.05%
23argenx SEARGX · SPONSORED ADRHealth Care0.63%$60.7M111.9K$542.082+ qtrsNo change
24Stoke Therapeutics IncSTOK—0.56%$53.7M4.37M$12.292+ qtrsNo change
25Immunocore Holdings plcIMCR · ADS—0.49%$47.2M1.52M$31.132+ qtrsNo change
26Kodiak Sciences IncKODHealth Care0.47%$45.2M17.31M$2.612+ qtrsNo change
27Sera Prognostics IncSERA · CLASS A COM—0.44%$42.4M5.43M$7.802+ qtrsNo change
28CRISPR Therapeutics AGCRSP · NAMEN AKTHealth Care0.41%$39.6M843.08K$46.982+ qtrs▲ Added 743%
29Xenon Pharmaceuticals IncXENE—0.41%$39.1M993.68K$39.372+ qtrsNo change
30Immunovant IncIMVTHealth Care0.36%$34.9M1.23M$28.512+ qtrs▲ Added 164%
31Cerus CorpCERS—0.35%$33.9M19.48M$1.742+ qtrsNo change
32IDEAYA Biosciences IncIDYA—0.35%$33.6M1.06M$31.682+ qtrsNo change
33Roivant Sciences LtdROIV · SHSHealth Care0.34%$32.3M2.8M$11.542+ qtrsNo change
34
Akero Therapeutics Incno ticker on file
—0.33%$31.5M1.1M$28.692+ qtrsNo change
35Krystal Biotech IncKRYSHealth Care0.32%$30.9M169.93K$182.032+ qtrsNo change
36Celcuity IncCELC—0.29%$28M1.87M$14.912+ qtrsNo change
37Monte Rosa Therapeutics IncGLUE—0.27%$26.1M4.92M$5.302+ qtrsNo change
38Dyne Therapeutics IncDYN—0.25%$24.1M672.1K$35.922+ qtrsNo change
39Biomea Fusion IncBMEA—0.22%$21.3M2.11M$10.102+ qtrsNo change
40Bicara Therapeutics IncBCAX—0.22%$21.2M833.33K$25.471 qtrNew
41Prelude Therapeutics IncPRLD—0.22%$21M10.12M$2.072+ qtrsNo change
42
Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS
—0.20%$19.6M1.23M$15.992+ qtrs▲ Added 123%
43Neurogene IncNGNE—0.20%$19.1M456.02K$41.962+ qtrsNo change
44Praxis Precision MedicinesPRAXHealth Care0.19%$18.6M323.11K$57.542+ qtrs▲ Added 146%
45Alumis IncALMS—0.17%$16.7M1.56M$10.682+ qtrsNo change
46
Merus N Vno ticker on file
—0.16%$15M300K$49.962+ qtrsNo change
47TScan Therapeutics IncTCRX—0.14%$13.9M2.78M$4.982+ qtrsNo change
48Neumora Therapeutics IncNMRA—0.14%$13.7M1.03M$13.212+ qtrsNo change
49Xencor IncXNCR—0.14%$13.5M670.43K$20.112+ qtrs▲ Added 23%
50
2seventy bio Incno ticker on file
—0.12%$11.8M2.5M$4.722+ qtrsNo change
51Fate Therapeutics IncFATE—0.11%$10.5M3M$3.502+ qtrsNo change
52Arvinas IncARVN—0.10%$10M405.58K$24.631 qtrNew
53Sana Biotechnology IncSANA—0.10%$9.9M2.38M$4.162+ qtrsNo change
54Design Therapeutics IncDSGN—0.10%$9.4M1.74M$5.382+ qtrs▲ Added 2.9%
55Ionis Pharmaceuticals IncIONSHealth Care0.09%$9M223.47K$40.061 qtrNew
56
Opthea Limitedno ticker on file · SPONSORED ADS
—0.09%$8.8M2.17M$4.072+ qtrsNo change
57Celldex Therapeutics IncCLDX—0.09%$8.4M247.64K$33.992+ qtrsNo change
58Relay Therapeutics IncRLAY—0.09%$8.2M1.16M$7.082+ qtrsNo change
59
Verve Therapeutics Incno ticker on file
—0.09%$8.2M1.69M$4.842+ qtrsNo change
60Taysha Gene Therapies IncTSHA—0.08%$8M4M$2.012+ qtrsNo change
61Mirum Pharmaceuticals IncMIRMHealth Care0.08%$7.4M190.48K$39.002+ qtrsNo change
62Contineum Therapeutics IncCTNM · CL A—0.06%$6M312.5K$19.142+ qtrsNo change
63Tango Therapeutics IncTNGX—0.06%$5.8M750K$7.702+ qtrsNo change
64Skye Bioscience IncSKYE—0.06%$5.6M1.43M$3.912+ qtrs▲ Added 187%
65Vaxcyte IncPCVXHealth Care0.06%$5.6M48.89K$114.272+ qtrsNo change
66
Crinetics Pharmaceuticalsno ticker on file
—0.06%$5.3M103.93K$51.102+ qtrsNo change
67DBV Technologies S.A.DBVT · SPONSORED ADR—0.05%$5.1M7.31M$0.70002+ qtrsNo change
68KALA BIO IncKALA—0.05%$5.1M891.34K$5.702+ qtrsNo change
69
Generation Bio Cono ticker on file
—0.05%$4.8M1.94M$2.472+ qtrs▲ Added 61%
70Alector IncALEC—0.05%$4.3M927.26K$4.662+ qtrsNo change
71Prime Medicine IncPRME—0.04%$4M1.03M$3.872+ qtrsNo change
72Sagimet Biosciences IncSGMT—0.04%$3.8M1.38M$2.772+ qtrsNo change
73Structure Therapeutics IncGPCR · SPONSORED ADS—0.04%$3.8M85.5K$43.891 qtrNew
74Arcturus Therapeutics HoldingsARCT—0.04%$3.5M151.33K$23.212+ qtrsNo change
75
HOOKIPA Pharma Incno ticker on file
—0.04%$3.5M812.81K$4.302+ qtrs▼ Reduced 90%
76
Leap Therapeutics Incno ticker on file
—0.03%$3M1.17M$2.572+ qtrsNo change
77Enliven Therapeutics IncELVN—0.03%$2.9M114.83K$25.542+ qtrsNo change
78Compass Therapeutics IncCMPX—0.03%$2.9M1.56M$1.842+ qtrsNo change
79Wave Life Sciences LtdWVE · SHS—0.03%$2.8M344.06K$8.201 qtrNew
80
Mersana Therapeutics Incno ticker on file
—0.02%$2.1M1.09M$1.892+ qtrsNo change
81Newamsterdam Pharma CompanyNAMS · ORDINARY SHARES—0.02%$1.6M96.71K$16.602+ qtrs▼ Reduced 0.1%
82Century Therapeutics IncIPSC—0.01%$1.4M797.46K$1.712+ qtrsNo change
83vTv Therapeutics IncVTVT · CL A—0.01%$1.3M97.31K$13.562+ qtrsNo change
84
Aerovate Therapeutics Incno ticker on file
—0.01%$1.3M628.94K$2.092+ qtrsNo change
85Pfizer IncPFEHealth Care0.01%$1M35K$28.942+ qtrsNo change
86Protara Therapeutics IncTARA—0.01%$982.4K536.83K$1.832+ qtrsNo change
87Aligos Therapeutics IncALGS—0.01%$719.3K83.06K$8.662+ qtrs—
88BioCryst Pharmaceuticals IncBCRX—0.01%$575.9K75.78K$7.602+ qtrsNo change
89PMV Pharmaceuticals IncPMVP—0.01%$479.8K322.02K$1.492+ qtrsNo change
90Foghorn Therapeutics IncFHTX—0.00%$419.2K45.03K$9.312+ qtrsNo change
91Acrivon Therapeutics IncACRV—0.00%$370.2K52.89K$7.002+ qtrsNo change
92Tyra Biosciences IncTYRA—0.00%$249.4K10.61K$23.512+ qtrsNo change
93
Surrozen Incno ticker on file · W EXP 8/11/2026
—0.00%$8.6K833.33K$0.01032+ qtrsNo change

By sector

Baker Brothers portfolio by sector, Q3 2024
SectorShare of portfolioValuePositions
Health Care75.4%$7.3B22
No sector on file24.6%$2.4B71

Questions and answers

What did Baker Brothers own in Q3 2024?

Baker Bros. Advisors's 13F for Q3 2024 lists 93 positions worth $9.6B. The largest: ONC (24.6%), INCY (21.1%), ACAD (6.8%), SMMT (5.5%), MDGL (4.3%).

What did Baker Brothers buy in Q3 2024?

The largest purchases, by the shares bought at the quarter-end price the filing implies: INSM (added, $61.3M), CRSP (added, $34.9M), SMMT (added, $26.3M), IMVT (added, $21.7M), BCAX (new, $21.2M), PRAX (added, $11M).

What did Baker Brothers sell in Q3 2024?

The largest sales: Insmed Incorporated (sold out, $56.2M), HOOKIPA Pharma Inc (reduced, $31.5M), Cerevel Therapeutics Hldng (sold out, $28M), Athira Pharma Inc (sold out, $8.4M), Talis Biomedical Corp (sold out, $4.4M), Adaptimmune Therapeutics (sold out, $2.3M).

When was this filing made?

Baker Bros. Advisors filed its 13F for the quarter ending Sep 30, 2024 on Nov 14, 2024. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Baker Brothers portfolio, Q3 2024: Baker Bros. Advisors 13F holdings”, data as of 14 November 2024. https://funkfolio.com/gurus/baker-brothers/2024-q3

Underlying data: SEC EDGAR, Form 13F-HR of Baker Bros. Advisors (CIK 1263508) for the period ending Sep 30, 2024.

Source: SEC EDGAR, Form 13F-HR for Baker Bros. Advisors (CIK 1263508), period ending Sep 30, 2024, filed Nov 14, 2024. Changes compare share counts with the filing for Jun 30, 2024; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $9.6B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 2 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.